Awadhesh K. Mishra
Durham University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Awadhesh K. Mishra.
Biotechnology Progress | 2000
Timothy J. Young; Simon Mawson; Keith P. Johnston; Inge B. Henriksen; Gary W. Pace; Awadhesh K. Mishra
Stable suspensions of submicron particles of cyclosporine, a water‐insoluble drug, have been produced by rapid expansion from supercritical to aqueous solution (RESAS). To minimize growth of the cyclosporine particles, which would otherwise occur in the free jet expansion, the solution was sprayed into an aqueous Tween‐80 (Polysorbate‐80) solution. Steric stabilization by the surfactant impedes particle growth and agglomeration. The particles were an order of magnitude smaller than those produced by RESS into air without the surfactant solution. Concentrations as high as 38 mg/mL for 400−700 nm particles were achieved in a 5.0% (w/w) Tween‐80 solution.
Aaps Pharmscitech | 2004
Timothy J. Young; Keith P. Johnston; Gary W. Pace; Awadhesh K. Mishra
The purpose of this research was to form stable suspensions of submicron particles of cyclosporine A, a water-insoluble drug, by rapid expansion from supercritical to aqueous solution (RESAS). A solution of cyclosporine A in CO2 was expanded into an aqueous solution containing phospholipid vesicles mixed with nonionic surfactants to provide stabilization against particle growth resulting from collisions in the expanding jet. The products were evaluated by measuring drug loading with high performance liquid chromatography (HPLC), particle sizing by dynamic light scattering (DLS), and particle morphology by transmission electron microscopy (TEM) and x-ray diffraction. The ability of the surfactant molecules to orient at the surface of the particles and provide steric stabilization could be manipulated by changing process variables including temperature and suspension concentration. Suspensions with high payloads (up to 54 mg/mL) could be achieved with a mean diameter of 500 nm and particle size distribution ranging from 40 to 920 nm. This size range is several hundred nanometers smaller than that produced by RESAS for particles stabilized by Tween 80 alone. The high drug payloads (≈10 times greater than the equilibrium solubility), the small particle sizes, and the long-term stability make this process attractive for development.
Archive | 1999
Gary W. Pace; Michael G. Vachon; Awadhesh K. Mishra; Inge B. Henrikson; Val Krukonis
Archive | 2000
Gary W. Pace; Awadhesh K. Mishra; Robert A. Snow
Archive | 1999
Indu Parikh; Awadhesh K. Mishra; Robert Donga; Michael G. Vachon
Archive | 1999
Awadhesh K. Mishra; Gary W. Pace; Michael G. Vachon
Archive | 2001
Gary W. Pace; Awadhesh K. Mishra
Archive | 2003
Indu Parikh; Awadhesh K. Mishra; Robert Donga; Michael G. Vachon
Archive | 2001
Awadhesh K. Mishra; Gary W. Pace; Robert A. Snow; Michael G. Vachon
Archive | 2002
Awadhesh K. Mishra; Michael G. Vachon; Pol-Henri Guivarc’h; Robert A. Snow; Gary W. Pace